Prodocs FY26 net profit rises 61% to ₹802 lakh, ESOP approved
Prodocs Solutions Limited reported a 61% increase in standalone net profit to ₹802.16 lakh for FY26, with revenue rising to ₹4,512.90 lakh. The board recommended a final dividend of ₹1 per share and approved the Prodocs Solutions Employee Stock Option Scheme 2026, covering 3,50,000 equity shares representing 4.96% of paid-up capital, subject to shareholder approval.

*this image is generated using AI for illustrative purposes only.
Prodocs Solutions Limited reported a 61% rise in standalone net profit to ₹802.16 lakh for the financial year ended March 31, 2026, compared to ₹498.22 lakh in the previous year. Revenue from operations increased to ₹4,512.90 lakh from ₹4,179.14 lakh in FY25. The board recommended a final dividend of ₹1 per equity share, aggregating to ₹70,50,000, subject to shareholder approval. Additionally, the board approved the formulation of the Prodocs Solutions Employee Stock Option Scheme 2026, covering 3,50,000 equity shares, subject to member approval.
Financial Performance
The company’s consolidated net profit for FY26 stood at ₹1,041.42 lakh. Total income for the year rose to ₹4,678.51 lakh on a standalone basis and ₹5,690.47 lakh on a consolidated basis. Earnings per share (EPS) on a standalone basis were ₹13.56 for FY26, compared to ₹13.89 in the previous year. The statutory auditor, M/s. A K Kocchar & Associates, issued an unmodified opinion on the financial results.
Operational Highlights
Prodocs Solutions operates in the information technology enabled services segment, with geographical presence in India and the USA. The USA market contributed significantly to the revenue, generating ₹4,072.54 lakh in standalone revenue for the year. The company’s cash and bank balance stood at ₹842.56 lakh as of March 31, 2026, up from ₹24.84 lakh in the previous year.
Corporate Governance and Appointments
The board approved the Prodocs Solutions Employee Stock Option Scheme 2026 for eligible employees and directors, including those of subsidiary companies. The scheme is in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The options correspond to 3,50,000 equity shares of ₹10 each, representing 4.96% of the paid-up share capital as on March 31, 2026, on a fully diluted basis. The pricing formula will be determined by the Compensation Committee, not less than face value and not more than the closing market price on the previous day of the grant. Vested options can be exercised within a period not exceeding one year from the date of vesting. The board also appointed M/s. KRS And Co. as Secretarial Auditors and M/s. Rahul Khubchandani & Co. as Internal Auditors for FY27, and approved the alteration of the Articles of Association.
Key Financial Metrics
| Metric | FY26 (₹ in Lakhs) | FY25 (₹ in Lakhs) |
|---|---|---|
| Revenue from Operations | 4,512.90 | 4,179.14 |
| Total Income | 4,678.51 | 4,277.53 |
| Total Expenses | 3,647.16 | 3,635.10 |
| Net Profit | 802.16 | 498.22 |
| Earnings Per Share (Basic) | 13.56 | 13.89 |
Historical Stock Returns for Prodocs Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.44% | -0.56% | -5.67% | +17.72% | +17.72% | +17.72% |
How does Prodocs Solutions plan to utilize the significant increase in cash and bank balances to drive future growth?
What strategic initiatives are being implemented to further expand market share in the USA?
Will the new Employee Stock Option Scheme be sufficient to retain key talent amidst industry competition?

































